stockrowImmuCell Corporation (ICCC) vs PMV Pharmaceuticals, Inc. (PMVP)
- ImmuCell Corporation ICCC 10.40 +1.76%
- PMV Pharmaceuticals, Inc. PMVP 1.23 −1.60%
ImmuCell Corporation and PMV Pharmaceuticals, Inc. are both Biotechnology companies. ImmuCell Corporation and PMV Pharmaceuticals, Inc. are of similar size ($94.4M and $92.8M). PMV Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; ImmuCell Corporation trades at 123×. ImmuCell Corporation has the higher net margin (2.57% vs 0.00%) and the higher return on invested capital (7.84% vs 0.00%). Across the 15 metrics below, ImmuCell Corporation leads on 11 and PMV Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | ICCC | PMVP | Biotechnology median |
|---|---|---|---|
| Gross margin | 40.32% | 0.00% | 68.51% |
| Operating margin | 12.60% | 0.00% | 0.00% |
| Net margin | 2.57% | 0.00% | 0.00% |
| Free cash flow margin | 13.79% | 0.00% | 0.00% |
| Return on equity | 2.57% | (70.93%) | (50.12%) |
| Return on assets | 1.69% | (64.04%) | (45.12%) |
| Return on invested capital | 7.84% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack